October 23, 2014 6:04 PM ET

Healthcare Equipment and Supplies

Company Overview of Immunetics, Inc.

Company Overview

Immunetics, Inc., a biotechnology company, researches and develops immunoassay and molecular probe kits and instruments for the diagnosis of infectious diseases. Its products include Miniblotter instrument system for western blot, spoligotyping, and various multi-probe membrane assays; cell adhesion flow chamber for cell-cell interaction studies; and C6 peptide Lyme ELISA, a synthetic peptide ELISA test for Lyme disease anthrax. The company’s products also include QuickELISA, a blood test for anthrax infection; and QualiCode western blot assays for diseases where diagnosis is challenging. In addition, it offers QuickELISA Anthrax-PA kit, an in vitro diagnostic test for the detection of antib...

27 Drydock Avenue

6th Floor

Boston, MA 02210

United States

Founded in 1987





Key Executives for Immunetics, Inc.

Chief Executive Officer and Director
Age: 54
Vice President of Finance
Vice President
Quality Assurance and Quality Control Director
Compensation as of Fiscal Year 2014.

Immunetics, Inc. Key Developments

Immunetics Introduces Updated BacTx Analyzer for Use with its BacTx Rapid Test for Bacterial Contamination of Platelets

Immunetics, Inc. introduced the updated BacTx(R) Analyzer for use with its BacTx rapid test for bacteria in whole-blood derived and apheresis platelets. The Analyzer offers automated interpretation, tracking, and documentation -- features that not only increase transfusion patient safety, but also provide seamless integration with the laboratory workplace. The BacTx assay gives hospitals and blood banks a practical tool for assuring the safety of their platelets. The colorimetric assay can detect aerobic, anaerobic, gram-negative and gram-positive bacteria in a single test. The test is designed to enable testing closer to time of transfusion, to reduce the risk of transfusing contaminated platelets. The updated BacTx Analyzer delivers a faster turnaround of results and a host of new automation and workflow-enhancement features. Complete assay results and analysis are delivered within 30 minutes. STAT, control, and standard assay capabilities allow for testing flexibility. Designed for simple, easy integration, the BacTx Analyzer fits seamlessly into the existing workflow of any laboratory or transfusion center.

Immunetics, Inc. Receives U.S. Food and Drug Administration Clearance for its BacTx(R) Rapid Test for Bacteria in Apheresis Platelets

Immunetics, Inc. has received U.S. Food and Drug Administration (FDA) clearance for its BacTx(R) rapid test for bacteria in apheresis platelets. The BacTx system is a colorimetric assay that can detect aerobic, anaerobic, gram-negative and gram-positive bacteria in a single test. The BacTx assay combines high sensitivity with simple, easy workflow integration. It utilizes a patented, highly specific, universal bacterial detection reagent that has been shown to detect wild and cultured bacterial strains. BacTx is intended for use as a point-of-issue test performed at the transfusion site on the day of issue. The BacTx assay can be used for quality control testing of: Leukocyte-reduced apheresis platelets (LRAP) within 24 hours of transfusion, following testing with an FDA-cleared growth-based bacterial detection device. Pools of up to six units of leukocyte-reduced whole-blood derived platelets that are pooled within 4 hours of transfusion.

Immunetics, Inc. Announces Executive Changes

Immunetics, Inc. announced that the company's Board of Directors has appointed John Yonkin as Chief Executive Officer. Mr. Yonkin will assume the post of CEO effective December 1, 2012. He will also serve as a member of the Board of Directors. Mr. Yonkin succeeds Dr. Andrew Levin, the company's founder. Dr. Levin will remain President at Immunetics and will continue to lead the Research and Development group.

Similar Private Companies By Industry

Company Name Region
Med Enclosure LLC United States
Thinoptx Inc. United States
Ceretec, Inc. United States
ActivAided Orthotics LLC United States
OMNI life science, Inc. United States

Recent Private Companies Transactions

Private Placement
February 26, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Immunetics, Inc., please visit www.immunetics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.